ATE234861T1 - Influenzaimpfstoff, der als sinergistischer zusatzmittel influenzavirusinnenkörper enthält - Google Patents

Influenzaimpfstoff, der als sinergistischer zusatzmittel influenzavirusinnenkörper enthält

Info

Publication number
ATE234861T1
ATE234861T1 AT92904852T AT92904852T ATE234861T1 AT E234861 T1 ATE234861 T1 AT E234861T1 AT 92904852 T AT92904852 T AT 92904852T AT 92904852 T AT92904852 T AT 92904852T AT E234861 T1 ATE234861 T1 AT E234861T1
Authority
AT
Austria
Prior art keywords
sinergistic
additional
influenza virus
internal body
vaccine containing
Prior art date
Application number
AT92904852T
Other languages
English (en)
Inventor
Catherine Moste-Deshairs
Bernard Meignier
Original Assignee
Aventis Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9409015&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE234861(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pasteur filed Critical Aventis Pasteur
Application granted granted Critical
Publication of ATE234861T1 publication Critical patent/ATE234861T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92904852T 1991-01-24 1992-01-24 Influenzaimpfstoff, der als sinergistischer zusatzmittel influenzavirusinnenkörper enthält ATE234861T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9100806A FR2671974A1 (fr) 1991-01-24 1991-01-24 Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal.
PCT/FR1992/000066 WO1992013002A1 (fr) 1991-01-24 1992-01-24 Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal

Publications (1)

Publication Number Publication Date
ATE234861T1 true ATE234861T1 (de) 2003-04-15

Family

ID=9409015

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92904852T ATE234861T1 (de) 1991-01-24 1992-01-24 Influenzaimpfstoff, der als sinergistischer zusatzmittel influenzavirusinnenkörper enthält

Country Status (10)

Country Link
EP (1) EP0522138B2 (de)
AT (1) ATE234861T1 (de)
AU (1) AU654699B2 (de)
CA (1) CA2078985C (de)
DE (1) DE69232962T3 (de)
FR (1) FR2671974A1 (de)
IL (1) IL100765A (de)
NZ (1) NZ241398A (de)
WO (1) WO1992013002A1 (de)
ZA (1) ZA92510B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994019013A1 (en) * 1993-02-19 1994-09-01 Smithkline Beecham Corporation Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a
FR2723740B1 (fr) * 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
WO1998046262A1 (en) * 1997-04-16 1998-10-22 Connaught Laboratories, Inc. Anti-influenza compositions supplemented with neuraminidase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483779A1 (fr) * 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
GB8502096D0 (en) * 1985-01-28 1985-02-27 Medical Res Council Influenza vaccine
US5136019A (en) * 1989-05-24 1992-08-04 Sri International Synthetic peptides for diagnosis and prevention of influenza virus infection and their use

Also Published As

Publication number Publication date
EP0522138A1 (de) 1993-01-13
EP0522138B2 (de) 2007-02-14
EP0522138B1 (de) 2003-03-19
AU654699B2 (en) 1994-11-17
FR2671974A1 (fr) 1992-07-31
AU1248792A (en) 1992-08-27
CA2078985C (fr) 2004-11-09
IL100765A0 (en) 1992-09-06
ZA92510B (en) 1992-11-25
IL100765A (en) 1996-06-18
WO1992013002A1 (fr) 1992-08-06
CA2078985A1 (fr) 1992-07-25
DE69232962T2 (de) 2005-06-23
DE69232962T3 (de) 2007-11-08
NZ241398A (en) 1994-08-26
DE69232962D1 (de) 2003-04-24
FR2671974B1 (de) 1995-03-03

Similar Documents

Publication Publication Date Title
DE3880047D1 (de) Zusammensetzung eines zusatzes.
NO924895L (no) Blekekatalysator, samt fremgangsmaate for bleking
ES2124479T3 (es) Composiciones biocidas.
DK0791571T3 (da) Benzoylderivater
TR200102120T2 (tr) 3-(2,4,6-trimetilfenil)-4-neopentilkarboniloksi-5, 5-tetrametilen-delta3-dihidrofuran-2-on'un beyaz sineği kontrol etmek için kullanımı.
DE69006854D1 (de) Anhaftende selbstverkapselnde spritzzusammensetzungen von bioregulatorischen agenzien.
DE69005841D1 (de) Alkoxyfunktionelle Harze und Zusammensetzungen, die Harze enthalten.
DE69322872D1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
DE69007908D1 (de) Shampoo-Zusammensetzung.
DE69128473D1 (de) An sigma-bindungsstellen wirkende stoffe
IT1240773B (it) Perfezionamento composizioni pozzolaniche.
NO903474D0 (no) Fremgangsmaate for fremstilling av neoalkyltrioltriestere.
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
DE69002520D1 (de) Azeotropaehnliche zusammensetzungen von 1,1-dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1-fluoraethan.
DK0391185T3 (da) 1,8-Naphthyridiner
DE58907381D1 (de) Ungesättigte Derivate von 2,2,6,6-Tetramethylpiperidin.
FI892222A0 (fi) Peptidalkoholer med antikoagulantverkan.
FR2692574B1 (fr) Derives hydroxy-4 benzenethio, leur preparation ainsi que leur utilisation pour la preparation de derives aminoalkoxybenzenesulfonyles.
ATE234861T1 (de) Influenzaimpfstoff, der als sinergistischer zusatzmittel influenzavirusinnenkörper enthält
DE59208398D1 (de) Neue synthetische Isohirudine mit verbesserter Stabilität
DE68910676D1 (de) Verwendung von Creosot als antispastischer Wirkstoff.
FI920423A0 (fi) Foerbaettringar i skaeranordning.
ES2056876T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
DE69006508D1 (de) Azeotropähnliche zusammensetzungen von 1,3-dichlor-1,1,2,2,3-pentafluorpropan und 2-methyl-2-propanol.
NO900635D0 (no) Herderblanding, samt anvendelse av den.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0522138

Country of ref document: EP

EEFA Change of the company name
UEP Publication of translation of european patent specification

Ref document number: 0522138

Country of ref document: EP

EELA Cancelled due to lapse of time